William P Fay Selected Research

Hyperglycemia

1/2020

Drug Targeting of Plasminogen Activator Inhibitor-1 Inhibits Metabolic Dysfunction and Atherosclerosis in a Murine Model of Metabolic Syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

William P Fay Research Topics

Disease

16	Thrombosis (Thrombus) 03/2012 - 01/2002
5	Vascular Diseases (Vascular Disease) 11/2016 - 09/2005
5	Hyperplasia 11/2016 - 07/2004
4	Atherosclerosis 01/2022 - 07/2004
4	Cardiovascular Diseases (Cardiovascular Disease) 07/2021 - 07/2013
4	Inflammation (Inflammations) 01/2020 - 11/2010
4	Neointima 11/2016 - 06/2002
4	Carotid Artery Injuries 10/2009 - 03/2002
3	Ischemia 01/2021 - 09/2011
3	Vascular System Injuries 11/2016 - 05/2003
2	Carcinoma (Carcinomatosis) 01/2021 - 07/2015
2	Neoplasms (Cancer) 01/2021 - 07/2015
2	Atherosclerotic Plaque (Atheroma) 01/2020 - 08/2011
2	Obesity 01/2020 - 01/2019
2	Vascular Remodeling 11/2016 - 09/2005
2	Myocardial Infarction 07/2013 - 07/2002
1	Infections 01/2022
1	Reperfusion Injury 01/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020
1	Hyperglycemia 01/2020
1	Glucose Intolerance 01/2019
1	Hypertension (High Blood Pressure) 05/2016
1	Venous Thrombosis (Deep-Vein Thrombosis) 07/2015
1	Venous Thromboembolism 07/2015
1	Coronary Artery Disease (Coronary Atherosclerosis) 07/2013
1	Diabetes Mellitus 07/2013
1	Infarction (Infarctions) 08/2011
1	Rupture 08/2011
1	Myocardial Ischemia (Ischemic Heart Diseases) 08/2011
1	Hemorrhage 11/2004
1	Streptococcal Infections (Streptococcal Infection) 08/2004
1	Iron Overload 05/2003

Drug/Important Bio-Agent (IBA)

9	Plasminogen Activator Inhibitor 1IBA 01/2021 - 06/2002
5	Plasminogen Activators (Plasminogen Activator)IBA 01/2020 - 06/2002
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2002
3	tiplaxtininIBA 01/2020 - 07/2015
3	Thrombin FDA Link 08/2011 - 01/2002
3	VitronectinIBA 08/2011 - 06/2002
2	Virulence Factors (Pathogenicity Factors)IBA 01/2022 - 08/2004
2	Fish OilsIBA 07/2021 - 05/2021
2	LDL Receptors (LDL Receptor)IBA 01/2020 - 03/2006
2	Pharmaceutical PreparationsIBA 11/2016 - 11/2004
2	FibrinIBA 08/2011 - 07/2004
2	C-Reactive ProteinIBA 11/2010 - 08/2003
2	ferric chlorideIBA 09/2010 - 09/2007
2	Peptide Hydrolases (Proteases)FDA Link 10/2009 - 09/2005
2	Thromboplastin (Tissue Factor)IBA 03/2006 - 01/2005
2	CollagenIBA 09/2005 - 08/2004
2	AnticoagulantsIBA 11/2004 - 07/2002
2	PlasminogenIBA 08/2004 - 07/2002
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2022
1	GW 4869IBA 01/2022
1	Caveolin 2IBA 01/2021
1	CholesterolIBA 01/2020
1	LipidsIBA 01/2020
1	Sucrose (Saccharose)IBA 01/2020
1	Triglycerides (Triacylglycerol)IBA 01/2020
1	Vasoconstrictor AgentsIBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	Endothelin-1 (Endothelin 1)IBA 01/2019
1	Janus KinasesIBA 11/2016
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 11/2016
1	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 11/2016
1	setanaxibIBA 05/2016
1	Interleukin-18 (Interleukin 18)IBA 05/2016
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 03/2016
1	GoldIBA 03/2016
1	Bevacizumab (Avastin)FDA Link 07/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2015
1	Plasminogen InactivatorsIBA 07/2015
1	Monoclonal AntibodiesIBA 07/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2013
1	Oxidoreductases (Dehydrogenase)IBA 07/2013
1	HomocysteineIBA 03/2012
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 09/2011
1	sodium bisulfide (NaHS)IBA 09/2011
1	AntithrombinsIBA 08/2011
1	Biomarkers (Surrogate Marker)IBA 11/2010
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 09/2010
1	Pancreatic Elastase (Elastase)IBA 10/2009
1	Fibrinolysin FDA Link 06/2007
1	ApolipoproteinsIBA 03/2006
1	Apolipoproteins E (ApoE)IBA 03/2006
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 09/2005
1	factor V LeidenIBA 12/2004
1	AntidotesIBA 11/2004
1	Streptokinase FDA Link 08/2004
1	Heme Oxygenase-1IBA 08/2004
1	Dextrans (Dextran)FDA Link 05/2003
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2003
1	Cysteine (L-Cysteine)FDA Link 05/2003
1	IronIBA 05/2003
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2003

Therapy/Procedure

2	Ligation 01/2005 - 06/2002
1	Glycemic Control 01/2019
1	Drug-Eluting Stents 03/2016
1	Secondary Prevention 07/2013
1	Intraperitoneal Injections 10/2009
1	Transplantation 01/2005